Samsung Bioepis first to receive EC approval for its third anti-TNF biosimilar
Samsung Bioepis Co., Ltd. last week announced the European Commission’s (EC) approval of Imraldi, a biosimilar referencing Humira (adalimumab). Imraldi is approved for the treatment of rheumatoid ...Sandoz proposed biosimilars rituximab and etanercept recommended for approval in Europe
Sandoz, announced that the Committee for Medicinal Products for Human Use (CHMP) has adopted positive opinions, separately recommending the approval of both Sandoz’ biosimilar rituximab and biosimilar ...Mylan and Biocon filed the biosimilar Herceptin application to FDA
Mylan N.V. and Biocon Ltd. last week announced submission of Mylan’s biologics license application (BLA) for MYL-1401O, a proposed biosimilar trastuzumab, to the U.S. Food and Drug Administration (FDA) ...
Medizone Germany GmbH · Keltenring 15 · 82041 Oberhaching · Germany · Phone +49(0)89/12112636 · Fax +49(0)89/12112637 · Impressum · Datenschutz · Imprint · Privacy Policy